Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer

We used the multiplex semi-quantitative reverse-transcriptase PCR (RT-PCR) to investigate kallikrein 2 and 3 (KLK2 and KLK3) mRNA levels in prostate tissue from 42 prostate cancer patients, 33 of whom were also assessed for peripheral blood KLK2 expression by qualitative semi-nested RT-PCR. We found...

Full description

Bibliographic Details
Main Authors: Juliana Meola, Luiz R. Goulart, Jaqueline D.D. Oliveira, Adriana F. Neves, Waldesse P. Oliveira Jr., Ana C.M. Saraiva, Andréia C. Capaneli, Alexandra M. Cardoso, Lindolfo D. Prado, Sebastião A. Borba, Heyder D. Silva
Format: Article
Language:English
Published: Sociedade Brasileira de Genética 2006-01-01
Series:Genetics and Molecular Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572006000200001
_version_ 1818368526380957696
author Juliana Meola
Luiz R. Goulart
Jaqueline D.D. Oliveira
Adriana F. Neves
Waldesse P. Oliveira Jr.
Ana C.M. Saraiva
Andréia C. Capaneli
Alexandra M. Cardoso
Lindolfo D. Prado
Sebastião A. Borba
Heyder D. Silva
author_facet Juliana Meola
Luiz R. Goulart
Jaqueline D.D. Oliveira
Adriana F. Neves
Waldesse P. Oliveira Jr.
Ana C.M. Saraiva
Andréia C. Capaneli
Alexandra M. Cardoso
Lindolfo D. Prado
Sebastião A. Borba
Heyder D. Silva
author_sort Juliana Meola
collection DOAJ
description We used the multiplex semi-quantitative reverse-transcriptase PCR (RT-PCR) to investigate kallikrein 2 and 3 (KLK2 and KLK3) mRNA levels in prostate tissue from 42 prostate cancer patients, 33 of whom were also assessed for peripheral blood KLK2 expression by qualitative semi-nested RT-PCR. We found that KLK2 was an important tissue biomarker for distinguishing between prostate cancer patients and those with benign prostatic hyperplasia, particularly when KLK2 expression was > 60% of that of the beta2-microglobulin constitutive gene. Patients with an average relative expression value > 0.6 (cutoff value) had an eleven-fold higher chance of having prostate cancer. When one or two tissues samples were evaluated for KLK2 expression using the cutoff value the estimated chance of having prostate cancer was increased by seven times for one positive sample and 45 times for two positive samples. There was no significant correlation between KLK3 gene expression and prostate cancer diagnosis. Logistic regression for blood and tissue KLK2 expression successfully detected 92% of the prostate cancer cases. The detection of KLK2 in blood showed a sensitivity of 59% and a specificity of 82%. This study indicates that the KLK2 gene may be a useful molecular marker for the diagnosis of prostate cancer and that analysis of KLK2 expression in blood and tissues could provide a novel approach for the clinical investigation of this type of cancer.
first_indexed 2024-12-13T23:09:21Z
format Article
id doaj.art-6ef375aac7064334ac4045efdeb6be44
institution Directory Open Access Journal
issn 1415-4757
1678-4685
language English
last_indexed 2024-12-13T23:09:21Z
publishDate 2006-01-01
publisher Sociedade Brasileira de Genética
record_format Article
series Genetics and Molecular Biology
spelling doaj.art-6ef375aac7064334ac4045efdeb6be442022-12-21T23:28:09ZengSociedade Brasileira de GenéticaGenetics and Molecular Biology1415-47571678-46852006-01-0129219319910.1590/S1415-47572006000200001Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancerJuliana MeolaLuiz R. GoulartJaqueline D.D. OliveiraAdriana F. NevesWaldesse P. Oliveira Jr.Ana C.M. SaraivaAndréia C. CapaneliAlexandra M. CardosoLindolfo D. PradoSebastião A. BorbaHeyder D. SilvaWe used the multiplex semi-quantitative reverse-transcriptase PCR (RT-PCR) to investigate kallikrein 2 and 3 (KLK2 and KLK3) mRNA levels in prostate tissue from 42 prostate cancer patients, 33 of whom were also assessed for peripheral blood KLK2 expression by qualitative semi-nested RT-PCR. We found that KLK2 was an important tissue biomarker for distinguishing between prostate cancer patients and those with benign prostatic hyperplasia, particularly when KLK2 expression was > 60% of that of the beta2-microglobulin constitutive gene. Patients with an average relative expression value > 0.6 (cutoff value) had an eleven-fold higher chance of having prostate cancer. When one or two tissues samples were evaluated for KLK2 expression using the cutoff value the estimated chance of having prostate cancer was increased by seven times for one positive sample and 45 times for two positive samples. There was no significant correlation between KLK3 gene expression and prostate cancer diagnosis. Logistic regression for blood and tissue KLK2 expression successfully detected 92% of the prostate cancer cases. The detection of KLK2 in blood showed a sensitivity of 59% and a specificity of 82%. This study indicates that the KLK2 gene may be a useful molecular marker for the diagnosis of prostate cancer and that analysis of KLK2 expression in blood and tissues could provide a novel approach for the clinical investigation of this type of cancer.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572006000200001kallikrein IImolecular markersprostate cancerPSAsemi-quantitative RT-PCR
spellingShingle Juliana Meola
Luiz R. Goulart
Jaqueline D.D. Oliveira
Adriana F. Neves
Waldesse P. Oliveira Jr.
Ana C.M. Saraiva
Andréia C. Capaneli
Alexandra M. Cardoso
Lindolfo D. Prado
Sebastião A. Borba
Heyder D. Silva
Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
Genetics and Molecular Biology
kallikrein II
molecular markers
prostate cancer
PSA
semi-quantitative RT-PCR
title Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
title_full Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
title_fullStr Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
title_full_unstemmed Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
title_short Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
title_sort differential expression of the klk2 and klk3 genes in peripheral blood and tissues of patients with prostate cancer
topic kallikrein II
molecular markers
prostate cancer
PSA
semi-quantitative RT-PCR
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572006000200001
work_keys_str_mv AT julianameola differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT luizrgoulart differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT jaquelineddoliveira differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT adrianafneves differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT waldessepoliveirajr differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT anacmsaraiva differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT andreiaccapaneli differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT alexandramcardoso differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT lindolfodprado differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT sebastiaoaborba differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer
AT heyderdsilva differentialexpressionoftheklk2andklk3genesinperipheralbloodandtissuesofpatientswithprostatecancer